Chue P

University of Alberta

2 papers

ArticleKetamine

A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)

Chue P, Silverstone P, Hillier T +6

Europe PMC2023
ArticlePsilocybin

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms

Chue P, Andreiev A, Bucuci E +2

Europe PMC2022